Circulating Thrombomodulin: Release Mechanisms, Measurements, and Levels in Diseases and Medical Procedures

Circulating Thrombomodulin: Release Mechanisms, Measurements, and Levels in Diseases and Medical Procedures

Thrombomodulin (TM) is a type-I transmembrane protein that is mainly expressed on endothelial cells and plays important roles in many biological processes. Circulating TM of different forms are also present in biofluids, such as blood and urine. Soluble TM (sTM), comprised of several domains of TM,...

Full description

Bibliographic Details
Main Authors:	Mallorie Boron, Tiffany Hauzer-Martin, Joseph Keil, Xue-Long Sun
Format:	Article
Language:	English
Published:	Georg Thieme Verlag KG 2022-07-01
Series:	TH Open
Subjects:	circulating thrombomodulin covid-19 endothelial cell microvesicle sepsis soluble thrombomodulin thrombomodulin vascular damage
Online Access:	http://www.thieme-connect.de/DOI/DOI?10.1055/a-1801-2055

Similar Items

The role of thrombomodulin lectin-like domain in inflammation
by: Li Yi-Heng, et al.
Published: (2012-03-01)

Value of Serum Thrombomodulin as a Marker and Predictor in Patients with Sepsis-Associated Acute Kidney Injury
by: Nguyen VT, et al.
Published: (2023-07-01)

Effect of dengue hemorrhagic fever on thrombomodulin level
by: Hendra Widjaja, et al.
Published: (2009-10-01)

Increased thrombomodulin level in hypertensive disorders of pregnancy
by: Zainab Abdul Abbas Hashim, et al.
Published: (2022-01-01)

Effects of combination therapy of antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a systematic review and meta-analysis
by: Takaaki Totoki, et al.
Published: (2024-01-01)

Simvastatin Prevents Liver Microthrombosis and Sepsis Induced Coagulopathy in a Rat Model of Endotoxemia
by: Vincenzo La Mura, et al.
Published: (2022-03-01)

Recombinant Thrombomodulin Suppresses Histone-Induced Neutrophil Extracellular Trap Formation
by: Binita Shrestha, et al.
Published: (2019-10-01)

Sepsis-Associated DIC with Decreased Levels of Antithrombin and Fibrinogen is the Target for Combination Therapy with Thrombomodulin Alfa and Antithrombin
by: Hideo Wada, et al.
Published: (2023-01-01)

Effects of recombinant human soluble thrombomodulin on neutrophil extracellular traps in the kidney of a mouse model of endotoxin shock
by: Tatsuhiko Harada, et al.
Published: (2023-08-01)

Recombinant human soluble thrombomodulin improves mortality in patients with sepsis especially for severe coagulopathy: a retrospective study
by: Takahiro Kato, et al.
Published: (2018-08-01)

Chondrocyte Thrombomodulin Protects against Osteoarthritis
by: Lin Kang, et al.
Published: (2023-05-01)

Coagulofibrinolytic effects of recombinant soluble thrombomodulin in prolonged porcine cardiac arrest
by: Boya Zhang, et al.
Published: (2023-12-01)

Endotheliopathy, Soluble Thrombomodulin and Its Role in Predicting Prognosis in Severe Coronavirus Disease-2019 Pneumonia
by: Hanife Usta Atmaca, et al.
Published: (2023-08-01)

Effects of combination therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation
by: Toshiaki Iba, et al.
Published: (2017-11-01)

Establishment of disseminated intravascular coagulation (DIC) model by a single iv administration of Escherichia coli-derived lipopolysaccharide (LPS) to cynomolgus monkeys and evaluation of its pathophysiological status
by: Hirofumi Minomo, et al.
Published: (2017-02-01)

Markers of acute kidney injury in patients with sepsis: the role of soluble thrombomodulin
by: Shinshu Katayama, et al.
Published: (2017-08-01)

Web-based application for predicting the potential target phenotype for recombinant human thrombomodulin therapy in patients with sepsis: analysis of three multicentre registries
by: Tadahiro Goto, et al.
Published: (2022-05-01)

Plasma thrombomodulin as a candidate biomarker for the diagnosis and prognosis of HBV-related acute-on-chronic liver failure
by: Zhou X, et al.
Published: (2024-03-01)

Angiopoietin-2 Inhibition of Thrombomodulin-Mediated Anticoagulation—A Novel Mechanism That May Contribute to Hypercoagulation in Critically Ill COVID-19 Patients
by: Michael Hultström, et al.
Published: (2022-06-01)

The relation of thrombomodulin G33A and C1418T gene polymorphisms to the risk of acute myocardial infarction in Egyptians
by: Wael Alkhiary, et al.
Published: (2018-01-01)

Recombinant thrombomodulin may protect cardiac capillary endothelial glycocalyx through promoting Glypican-1 expression under experimental endotoxemia
by: Yoshinori Kakino, et al.
Published: (2022-11-01)

The effect of recombinant human soluble thrombomodulin on renal function and mortality in septic disseminated intravascular coagulation patients with acute kidney injury: a retrospective study
by: Masayuki Akatsuka, et al.
Published: (2020-12-01)

Prognostic factors in patients with septic disseminated intravascular coagulation treated with thrombomodulin: the effect of reduced thrombomodulin dose; a single-center, retrospective, observational study
by: Yoshihiro Nishita, et al.
Published: (2022-12-01)

Recombinant Human Soluble Thrombomodulin Suppresses Monocyte Adhesion by Reducing Lipopolysaccharide-Induced Endothelial Cellular Stiffening
by: Takayuki Okamoto, et al.
Published: (2020-07-01)

Assessment of Serum Thrombomodulin in Patients with Systemic Lupus Erythematosus in Rheumatology Research Center
by: Mahmood Akbarian, et al.
Published: (2009-04-01)

The involvement of endothelial mediators in leprosy
by: Maria Renata Sales Nogueira, et al.

Association of endothelial and glycocalyx injury biomarkers with fluid administration, development of acute kidney injury, and 90-day mortality: data from the FINNAKI observational study
by: Nina Inkinen, et al.
Published: (2019-09-01)

Thrombomodulin Serum Levels—A Predictable Biomarker for the Acute Onset of Ischemic Stroke
by: Andrei-Lucian Zaharia, et al.
Published: (2024-01-01)

The chondroitin sulfate moiety mediates thrombomodulin-enhanced adhesion and migration of vascular smooth muscle cells
by: Vincent Chunpeng Pai, et al.
Published: (2018-02-01)

The pathophysiology, diagnosis, and management of sepsis-associated disseminated intravascular coagulation
by: Toshiaki Iba, et al.
Published: (2023-05-01)

Comparison of thrombomodulin, vWF, and ADAMTS13 levels between preeclampsia and normal pregnancy
by: Aisha Ahmad, et al.
Published: (2023-12-01)

The Role of Thrombomodulin in Estrogen-Receptor-Positive Breast Cancer Progression, Metastasis, and Curcumin Sensitivity
by: Chien-Yu Huang, et al.
Published: (2023-05-01)

Therapeutic Role of Recombinant Human Soluble Thrombomodulin for Acute Exacerbation of Idiopathic Pulmonary Fibrosis
by: Takuma Isshiki, et al.
Published: (2019-05-01)

Effects of Thrombomodulin in Reducing Lethality and Suppressing Neutrophil Extracellular Trap Formation in the Lungs and Liver in a Lipopolysaccharide-Induced Murine Septic Shock Model
by: Yu Kato, et al.
Published: (2021-05-01)

Recombinant human soluble thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis: a nationwide observational study
by: Nobuyasu Awano, et al.
Published: (2022-03-01)

Absence of the lectin-like domain of thrombomodulin reduces HSV-1 lethality of mice with increased microglia responses
by: Meng-Shan Tsai, et al.
Published: (2022-03-01)

Changes and significance of vascular endothelial injury markers in patients with diabetes mellitus and pulmonary thromboembolism
by: Fan Li, et al.
Published: (2023-05-01)

Thrombomodulin expression impacts the recurrence and long‐term survival in pancreatic cancer
by: Hiroshi Sugano, et al.
Published: (2021-07-01)

Endothelial thrombomodulin downregulation caused by hypoxia contributes to severe infiltration and coagulopathy in COVID-19 patient lungs
by: Taejoon Won, et al.
Published: (2022-01-01)

Effects of thrombomodulin alfa on hemostatic parameters in disseminated intravascular coagulation: Post hoc analysis of a phase 3 randomized controlled trial
by: Takashi Ito, et al.
Published: (2020-10-01)